Results 131 to 140 of about 29,292 (187)

Analysis of risk factors for the development of bronchiolitis obliterans in children with severe <i>Mycoplasma pneumoniae</i> pneumonia. [PDF]

Front Med (Lausanne)
Hou J, Sun R, Ding Z, Jia W, Li P, Fu S, Song C.   +6 more
europepmc   +1 more source

Development of a predictive model based on clinical indicators for refractory Mycoplasma pneumoniae pneumonia in children: a case-control study. [PDF]

Front Cell Infect Microbiol
Yu F, Zhou Y, Luo Z.
europepmc   +1 more source

Severe Mycoplasma pneumoniae Pneumonia During the 2023-2024 European Re-Emergence: Why Severity Does Not Predict Macrolide Resistance. [PDF]

Antibiotics (Basel)
Perugini E, Ferrari L, Iannetta M, Bartolini B, Dimartino V, Favaro M, Fontana C, Sarmati L.   +7 more
europepmc   +1 more source

Serum vitamins and <i>Mycoplasma pneumoniae</i> pneumonia in children: a case-control study. [PDF]

Front Immunol
Li T, Chen N, Wang X, Li X, Fang P, Yang J, Jin Z.   +6 more
europepmc   +1 more source

Changes in Epidemiological Characteristics in Children with <i>Mycoplasma pneumoniae</i> Seropositivity in Southwest China from 2022 to 2023. [PDF]

J Clin Med
Gao Z, Duan Y, Wu Y, Gou Y, Yu F.
europepmc   +1 more source

A nomogram prediction model for plastic bronchitis in children with refractory <i>Mycoplasma pneumoniae</i> pneumonia. [PDF]

Front Pediatr
He H, Kuang Z, Zhang Z, Rao G, Xiong C, Lu L, Yang C, Song Y.   +7 more
europepmc   +1 more source

Post-pandemic resurgence and collapse of <i>Mycoplasma pneumoniae</i> in hospitalized children: a four-year multiplex surveillance study in China. [PDF]

Front Public Health
Hu H.
europepmc   +1 more source